A Prospective Study of the Dry Eye Drink That Evaluates Hydration and Subject's Assessment on Eye Dryness
NCT05949697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-03-26
Summary
A study to assess the effect of the Dry Eye Drink on eye dryness
Conditions
- Dry Eye
Interventions
- DIETARY_SUPPLEMENT
-
Dry Eye Drink
Dry Eye Drink is a dietary supplement containing electrolytes, vitamins and natural anti-inflammatories.
Sponsors & Collaborators
-
CBCC Global Research
collaborator NETWORK -
Bruder Healthcare
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
Soothe Versus Refresh
NCT00284999 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics
NCT01450787 ·Status: TERMINATED
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
NCT00567177 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
NCT05784519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
NCT05857748 ·Status: WITHDRAWN
-
Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed With Dry Eye Disease in A Sample of Egyptian Patients
NCT05598437 ·Status: UNKNOWN
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
NCT03888183 ·Status: UNKNOWN ·Phase: PHASE4
-
PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities
NCT05823961 ·Status: COMPLETED ·Phase: NA
-
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
NCT01614847 ·Status: COMPLETED ·Phase: PHASE4
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 ·Status: UNKNOWN ·Phase: PHASE3